FdaApplication
BLA 103914
Identifiers
- fda_app_no: BLA103914
Properties
| Property | Value |
|---|---|
| applicant_name | Sanofi Vaccines US Inc. |
| application_type | BLA |
| approval_date | 1999-12-09 |
Products (10)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| FLUZONE, FLUZONE HD QUADRIVALENT, FLUZONE HIGH DOSE, FLUZONE INTRADERMAL, FLUZONE QUADRIVALENT | — | 45UG/.5ML | Injection |
| FLUZONE, FLUZONE HD QUADRIVALENT, FLUZONE HIGH DOSE, FLUZONE INTRADERMAL, FLUZONE QUADRIVALENT | — | 36UG/.5ML | Injection |
| FLUZONE, FLUZONE HD QUADRIVALENT, FLUZONE HIGH DOSE, FLUZONE INTRADERMAL, FLUZONE QUADRIVALENT | — | 60UG/.5ML | Injection |
| FLUZONE, FLUZONE HD QUADRIVALENT, FLUZONE HIGH DOSE, FLUZONE INTRADERMAL, FLUZONE QUADRIVALENT | — | 45UG/.5ML | Injection |
| FLUZONE, FLUZONE HD QUADRIVALENT, FLUZONE HIGH DOSE, FLUZONE INTRADERMAL, FLUZONE QUADRIVALENT | — | 45UG/.5ML | Injection |
| FLUZONE, FLUZONE HD QUADRIVALENT, FLUZONE HIGH DOSE, FLUZONE INTRADERMAL, FLUZONE QUADRIVALENT | — | 180 UG/.5ML | Injection |
| FLUZONE, FLUZONE HD QUADRIVALENT, FLUZONE HIGH DOSE, FLUZONE INTRADERMAL, FLUZONE QUADRIVALENT | — | 60UG/.5ML | Injection |
| FLUZONE, FLUZONE HD QUADRIVALENT, FLUZONE HIGH DOSE, FLUZONE INTRADERMAL, FLUZONE QUADRIVALENT | — | 27UG/0.1 | Injection |
| FLUZONE, FLUZONE HD QUADRIVALENT, FLUZONE HIGH DOSE, FLUZONE INTRADERMAL, FLUZONE QUADRIVALENT | — | 60UG/.5ML | Injection |
| FLUZONE, FLUZONE HD QUADRIVALENT, FLUZONE HIGH DOSE, FLUZONE INTRADERMAL, FLUZONE QUADRIVALENT | — | 240UG/.7ML | Injection |
10 products